Page last updated: 2024-10-28

phenelzine and Narcolepsy

phenelzine has been researched along with Narcolepsy in 2 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Narcolepsy: A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murphy, DL1
Sunderland, T1
Cohen, RM1
Wyatt, RJ1
Fram, DH1
Buchbinder, R1
Snyder, F1

Reviews

1 review available for phenelzine and Narcolepsy

ArticleYear
Monoamine oxidase-inhibiting antidepressants. A clinical update.
    The Psychiatric clinics of North America, 1984, Volume: 7, Issue:3

    Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Diet; Drug Interactions; D

1984

Trials

1 trial available for phenelzine and Narcolepsy

ArticleYear
Treatment of intractable narcolepsy with a monoamine oxidase inhibitor.
    The New England journal of medicine, 1971, Oct-28, Volume: 285, Issue:18

    Topics: Adult; Cataplexy; Clinical Trials as Topic; Dreams; Edema; Electroencephalography; Electromyography;

1971